Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
male (67) 67
cardiac & cardiovascular systems (56) 56
female (56) 56
index medicus (52) 52
aged (33) 33
cardiovascular (33) 33
aged, 80 and over (32) 32
middle aged (27) 27
stenosis (26) 26
treatment outcome (26) 26
life sciences (25) 25
aortic valve stenosis - surgery (23) 23
heart valve diseases (22) 22
internal medicine (22) 22
prosthesis (21) 21
follow-up studies (20) 20
heart valve prosthesis implantation - methods (19) 19
mortality (18) 18
adult (17) 17
cardiology (17) 17
replacement (17) 17
abridged index medicus (16) 16
aortic stenosis (16) 16
time factors (16) 16
echocardiography (15) 15
heart valve prosthesis (15) 15
implantation (15) 15
prospective studies (15) 15
aortic valve stenosis (14) 14
animals (13) 13
cardiology and cardiovascular medicine (13) 13
care and treatment (13) 13
electrocardiography (13) 13
heart attacks (13) 13
retrospective studies (13) 13
stents (13) 13
analysis (11) 11
implants, artificial (11) 11
patients (11) 11
prosthesis design (11) 11
risk factors (11) 11
cardiac catheterization - methods (10) 10
coronary vessels (10) 10
heart (10) 10
predictive value of tests (10) 10
aortic valve - surgery (9) 9
coronary angiography (9) 9
follow-up (9) 9
multivariate analysis (9) 9
myocardial infarction (9) 9
reperfusion (9) 9
angioplasty (8) 8
aortic valve stenosis - diagnostic imaging (8) 8
cardiac patients (8) 8
cardiovascular disease (8) 8
experience (8) 8
human health and pathology (8) 8
outcomes (8) 8
patient outcomes (8) 8
prostheses (8) 8
stroke (8) 8
transcatheter aortic valve replacement (8) 8
[sdv]life sciences [q-bio] (7) 7
aortic valve (7) 7
aortic valve stenosis - diagnosis (7) 7
aortic valve stenosis - therapy (7) 7
cardiology and cardiovascular system (7) 7
complications (7) 7
confidence intervals (7) 7
coronary disease - diagnostic imaging (7) 7
feasibility studies (7) 7
health aspects (7) 7
heart failure (7) 7
hemodynamics (7) 7
high-risk patients (7) 7
immunology (7) 7
incidence (7) 7
ischemia (7) 7
predictors (7) 7
rats (7) 7
registries (7) 7
registry (7) 7
severity of illness index (7) 7
[ sdv ] life sciences [q-bio] (6) 6
adolescent (6) 6
angiography (6) 6
angioplasty, balloon, coronary (6) 6
anticoagulants (6) 6
aortic valve - diagnostic imaging (6) 6
aortic valve stenosis - mortality (6) 6
bioprosthesis (6) 6
catheters (6) 6
child (6) 6
corevalve (6) 6
coronary disease - physiopathology (6) 6
femoral artery (6) 6
france (6) 6
france - epidemiology (6) 6
heart valve prosthesis implantation - adverse effects (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry
by Gilard, Martine and Eltchaninoff, Hélène and Donzeau-Gouge, Patrick and Chevreul, Karine and Fajadet, Jean and Leprince, Pascal and Leguerrier, Alain and Lievre, Michel and Prat, Alain and Teiger, Emmanuel and Lefevre, Thierry and Tchetche, Didier and Carrié, Didier and Himbert, Dominique and Albat, Bernard and Cribier, Alain and Sudre, Arnaud and Blanchard, Didier and Rioufol, Gilles and Collet, Frederic and Houel, Remi and Dos Santos, Pierre and Meneveau, Nicolas and Ghostine, Said and Manigold, Thibaut and Guyon, Philippe and Grisoli, Dominique and Le Breton, Herve and Delpine, Stephane and Didier, Romain and Favereau, Xavier and Souteyrand, Geraud and Ohlmann, Patrick and Doisy, Vincent and Grollier, Gilles and Gommeaux, Antoine and Claudel, Jean-Philippe and Bourlon, Francois and Bertrand, Bernard and Laskar, Marc and Iung, Bernard and Gilard, Martine and Laskar, Marc and Eltchaninoff, Hélène and Fajadet, Jean and Iung, Bernard and Teiger, Emmanuel and Donzeau-Gouge, Patrick and Leprince, Pascal and Leguerrier, Alain and Prat, Alain and Chevreul, Karine and Lievre, Michel and Bertrand, Michel and Cassagne, Jean and Boschat, Jacques and Lusson, Jean Rene and Mathieu, Pierre and Logeais, Yves and Bessou, Jean-Paul and Lefevre, Thierry and Chevalier, Bernard and Farge, Arnaud and Garot, Philippe and Hovasse, Thomas and Morice, Marie Claude and Romano, Mauro and Gouge, Patrick Donzeau and Tchetche, Didier and Vahdat, Olivier and Farah, Bruno and Fajadet, Jean and Carrie, Didier and Dumonteil, Nicolas and Fournial, Gérard and Marcheix, Bertrand and Himbert, Dominique and Nataf, Patrick and Vahanian, Alec and Albat, Bernard and Leclercq, Florence and Piot, Christophe and Schmutz, Laurent and Aubas, Pierre and du Cailar, A and Dubar, A and Durrleman, N and Fargosz, F and Levy, Gilles and Maupas, Eric and Rivalland, François and Robert, G and Eltchaninoff, Hélène and Bessou, Jean-Paul and Cribier, Alain and Tron, Christophe and Sudre, Arnaud and Juthier, Francis and Modine, Thomas and Van Belle, Eric and ... and FRANCE 2 Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2016, Volume 68, Issue 15, pp. 1637 - 1647
Background Transcatheter aortic valve replacement (TAVR) has revolutionized management of high-risk patients with severe aortic stenosis. However, survival and... 
aortic stenosis | risk score | predictive analysis | MORTALITY | SURVIVAL | LATE CLINICAL-OUTCOMES | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | PREDICTORS | LONG-TERM OUTCOMES | COREVALVE | PERMANENT PACEMAKER IMPLANTATION | 2-YEAR OUTCOMES | Transcatheter Aortic Valve Replacement | Prospective Studies | Risk Assessment | Time Factors | Humans | Aged, 80 and over | Female | Male | Registries | Treatment Outcome | Aortic Valve Stenosis - surgery | France | Heart valve diseases | Valves | Patient outcomes | Prostheses | Survival analysis | Heart attacks | Patients | Mortality | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Comparison of Two Antiplatelet Therapy Strategies in Patients Undergoing Transcatheter Aortic Valve Implantation
by Durand, Eric, MD, PhD and Blanchard, Didier, MD and Chassaing, Stephan, MD and Gilard, Martine, MD, PhD and Laskar, Marc, MD and Borz, Bogdan, MD and Lafont, Antoine, MD, PhD and Barbey, Christophe, MD and Godin, Matthieu, MD and Tron, Christophe, MD and Zegdi, Rachid, MD, PhD and Chatel, Didier, MD and Le Page, Olivier, MD and Litzler, Pierre-Yves, MD, PhD and Bessou, Jean-Paul, MD and Danchin, Nicolas, MD and Cribier, Alain, MD and Eltchaninoff, Hélène, MD
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 2, pp. 355 - 360
Dual antiplatelet therapy is commonly used in patients undergoing transcatheter aortic valve implantation (TAVI), but the optimal antiplatelet regimen is... 
Cardiovascular | REPLACEMENT | HIGH-RISK PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | FEASIBILITY | EDWARDS SAPIEN | HEART-VALVE | FOLLOW-UP | EXPERIENCE | PROSTHESIS | REGISTRY | Cardiac Catheterization - standards | France - epidemiology | Stroke - prevention & control | Heart Valve Prosthesis Implantation - standards | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Heart Valve Prosthesis Implantation - methods | Male | Aortic Valve Stenosis - therapy | Incidence | Aged, 80 and over | Female | Stroke - epidemiology | Platelet Aggregation Inhibitors - therapeutic use | Postoperative Complications | Practice Guidelines as Topic | Heart valve diseases | Care and treatment | Comparative analysis | Health aspects | Mortality | Confidence intervals | Variables | Stroke | Heart attacks | Hospitals | Tomography | Cardiovascular disease | Drug therapy | Multivariate analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cyclosporine before PCI in Patients with Acute Myocardial Infarction
by Cung, Thien-Tri and Morel, Olivier and Cayla, Guillaume and Rioufol, Gilles and Garcia-Dorado, David and Angoulvant, Denis and Bonnefoy-Cudraz, Eric and Guérin, Patrice and Elbaz, Meier and Delarche, Nicolas and Coste, Pierre and Vanzetto, Gerald and Metge, Marc and Aupetit, Jean-François and Jouve, Bernard and Motreff, Pascal and Tron, Christophe and Labeque, Jean-Noel and Steg, Philippe Gabriel and Cottin, Yves and Range, Grégoire and Clerc, Jérome and Claeys, Marc J and Coussement, Patrick and Prunier, Fabrice and Moulin, Frédéric and Roth, Olivier and Belle, Loïc and Dubois, Philippe and Barragan, Paul and Gilard, Martine and Piot, Christophe and Colin, Patrice and De Poli, Fabien and Morice, Marie-Claude and Ider, Omar and Dubois-Randé, Jean-Luc and Unterseeh, Thierry and Le Breton, Hervé and Béard, Thierry and Blanchard, Didier and Grollier, Gilles and Malquarti, Vincent and Staat, Patrick and Sudre, Arnaud and Elmer, Eskil and Hansson, Magnus J and Bergerot, Cyrille and Boussaha, Inesse and Jossan, Claire and Derumeaux, Geneviève and Mewton, Nathan and Ovize, Michel and Clinical Neurophysiology and Klinisk fysiologi, Lund and Mitochondrial Medicine and Department of Clinical Physiology (Lund) and Lund University and Klinisk neurofysiologi and Mitokondriell Medicin and Lunds universitet
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 1021 - 1031
Patients with acute STEMI undergoing PCI were assigned to cyclosporine or placebo. No significant between-group difference was seen in the rate of death,... 
HEART | MEDICINE, GENERAL & INTERNAL | MITOCHONDRIAL PERMEABILITY TRANSITION | PERCUTANEOUS CORONARY INTERVENTION | INJECTION | REPERFUSION INJURY | SIZE | PORE | ISCHEMIA | CARDIOPROTECTION | ASPIRATION | Enzyme Inhibitors - adverse effects | Injections, Intravenous | Double-Blind Method | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Male | Combined Modality Therapy | Enzyme Inhibitors - administration & dosage | Cyclophilins - antagonists & inhibitors | Myocardial Infarction - therapy | Myocardial Infarction - drug therapy | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Electrocardiography | Female | Aged | Heart Failure - epidemiology | Ventricular Remodeling - drug effects | Percutaneous Coronary Intervention | Care and treatment | Usage | Angiography | Heart enlargement | Dosage and administration | Cyclosporine | Heart attack | Occlusion | Myocardial infarction | Heart | Cerebral infarction | Heart attacks | Intravenous administration | Cyclosporins | Angioplasty | Body weight | Coronary artery | Clinical trials | Angina | Patients | Clinical outcomes | Reperfusion | Ventricle | Drug therapy | Heart diseases | Pharmaceuticals | Life Sciences | Bioengineering | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years
by Iung, Bernard and Armoiry, Xavier and Vahanian, Alec and Boutitie, Florent and Mewton, Nathan and Trochu, Jean-Noël and Lefèvre, Thierry and Messika-Zeitoun, David and Guerin, Patrice and Cormier, Bertrand and Brochet, Eric and Thibault, Hélène and Himbert, Dominique and Thivolet, Sophie and Leurent, Guillaume and Bonnet, Guillaume and Donal, Erwan and Piriou, Nicolas and Piot, Christophe and Habib, Gilbert and Rouleau, Frédéric and Carrié, Didier and Nejjari, Mohammed and Ohlmann, Patrick and Etienne, Christophe Saint and Leroux, Lionel and Gilard, Martine and Samson, Géraldine and Rioufol, Gilles and Maucort-Boulch, Delphine and Obadia, Jean François and MITRA-FR Investigators and on behalf of the MITRA‐FR Investigators
European journal of heart failure, ISSN 1388-9842, 09/2019
The MITRA-FR trial showed that among symptomatic patients with severe secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Membrane-Bound Hydrogenase I from the Hyperthermophilic Bacterium Aquifex aeolicus: Enzyme Activation, Redox Intermediates and Oxygen Tolerance
by Pandelia, Maria-Eirini and Fourmond, Vincent and Tron-Infossi, Pascale and Lojou, Elisabeth and Bertrand, Patrick and Léger, Christophe and Giudici-Orticoni, Marie-Thérèse and Lubitz, Wolfgang
Journal of the American Chemical Society, ISSN 0002-7863, 05/2010, Volume 132, Issue 20, pp. 6991 - 7004
The membrane-bound hydrogenase (Hase I) of the hyperthermophilic bacterium Aquifex aeolicus belongs to an intriguing class of redox enzymes that show enhanced... 
ACTIVE-SITE | CARBON-MONOXIDE | NIFE HYDROGENASE | CRYSTAL-STRUCTURE | SPECTROELECTROCHEMICAL CHARACTERIZATION | ALLOCHROMATIUM-VINOSUM | RALSTONIA-EUTROPHA | DESULFOVIBRIO-GIGAS HYDROGENASE | NAD-REDUCING HYDROGENASE | OXIDIZED STATES | CHEMISTRY, MULTIDISCIPLINARY | Anaerobiosis | Oxygen - pharmacology | Catalytic Domain | Biocatalysis | Oxidation-Reduction | Models, Molecular | Hydrogenase - chemistry | Enzyme Activation - drug effects | Potentiometry | Spectroscopy, Fourier Transform Infrared | Oxygen - metabolism | Electrodes | Gram-Negative Bacteria - enzymology | Hydrogenase - metabolism | Solutions | Electrochemistry | Gram-Negative Bacteria - cytology | Cell Membrane - metabolism | Kinetics | Hydrogen-Ion Concentration | Enzyme inhibitors | Analysis | Bacteria, Thermophilic | Physiological aspects | Genetic aspects | Chemical properties | Oxidoreductases | Structure | Hydrogenation | Electric properties | Life Sciences | Molecular biology | Biochemistry, Molecular Biology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)
by Mewton, Nathan, MD, PhD and Cung, Thien T., MD and Morel, Olivier, MD, PhD and Cayla, Guillaume, MD, PhD and Bonnefoy-Cudraz, Eric, MD, PhD and Rioufol, Gilles, MD, PhD and Angoulvant, Denis, MD, PhD and Guerin, Patrice, MD, PhD and Elbaz, Meyer, MD, PhD and Delarche, Nicolas, MD and Coste, Pierre, MD, PhD and Vanzetto, Gerald, MD, PhD and Metge, Marc, MD and Aupetit, Jean-François, MD and Jouve, Bernard, MD and Motreff, Pascal, MD, PhD and Tron, Christophe, MD and Labeque, Jean-Noël, MD and Steg, Pierre G., MD, PhD and Cottin, Yves, MD, PhD and Range, Grégoire, MD and Clerc, Jerome, MD and Coussement, Patrick, MD and Prunier, Fabrice, MD, PhD and Moulin, Frederique, MD and Roth, Olivier, MD and Belle, Loic, MD and Dubois, Phillipe, MD and Barragan, Paul, MD and Gilard, Martine, MD, PhD and Piot, Christophe, MD, PhD and Colin, Patrice, MD and Morice, Marie-Claude, MD and Monassier, Jean-Pierre, MD and Ider, Omar, MD and Dubois-Randé, Jean Luc P., MD, PhD and Unterseeh, Thierry, MD and Lebreton, Hervé, MD, PhD and Beard, Thierry, MD and Blanchard, Didier, MD and Grollier, Gilles, MD and Malquarti, Vincent, MD and Staat, Patrick, MD and Sudre, Arnaud, MD and Hansson, Magnus J., MD and Elmer, Eskil, PhD and Boussaha, Inesse, MSc and Jossan, Claire, MSc and Torner, Anna and Claeys, Marc, MD, PhD and Garcia-Dorado, David, MD, PhD and Ovize, Michel, MD, PhD and CIRCUS Study Investigators
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 6, pp. 758 - 766.e6
Background Both acute myocardial ischemia and reperfusion contribute to cardiomyocyte death in ST-elevation myocardial infarction (STEMI). The final infarct... 
Cardiovascular | HEART | MITOCHONDRIAL PERMEABILITY TRANSITION | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | REPERFUSION INJURY | PORE | SIZE | MAGNETIC-RESONANCE | NO-REFLOW PHENOMENON | SEGMENT-ELEVATION | CELL-DEATH | Myocardial Infarction - surgery | Echocardiography | Prospective Studies | Double-Blind Method | Humans | Male | Treatment Outcome | Biomarkers - blood | Coronary Angiography | Cyclosporine - therapeutic use | Time Factors | Cyclosporine - adverse effects | Electrocardiography | Female | Myocardial Infarction - physiopathology | Percutaneous Coronary Intervention | Patient outcomes | Cardiac patients | Heart attack | Heart failure | Hypotheses | Heart attacks | Mortality | Rodents | Cardiomyocytes | Hospitalization | Permeability | Circuses | Life Sciences | Bioengineering
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Diagnostic Performance of Computed Tomography Coronary Angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)
by Gueret, Pascal, MD and Deux, Jean-François, MD and Bonello, Laurent, MD and Sarran, Anthony, MD and Tron, Christophe, MD and Christiaens, Luc, MD and Dacher, Jean-Nicolas, MD and Bertrand, David, MD and Leborgne, Laurent, MD and Renard, Cedric, MD and Caussin, Christophe, MD and Cluzel, Philippe, MD and Helft, Gerard, MD and Crochet, Dominique, MD and Vernhet-Kovacsik, Hélène, MD, PhD and Chabbert, Valérie, MD and Ferrari, Emile, MD and Gilard, Martine, MD and Willoteaux, Serge, MD and Furber, Alain, MD and Barone-Rochette, Gilles, MD and Jankowski, Adrien, MD and Douek, Philippe, MD and Mousseaux, Elie, MD and Sirol, Marc, MD and Niarra, Ralph, MSc and Chatellier, Gilles, MD and Laissy, Jean-Pierre, MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 111, Issue 4, pp. 471 - 478
Computed tomographic coronary angiography (CTCA) has been proposed as a noninvasive test for significant coronary artery disease (CAD), but only limited data... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | TASK-FORCE | HEART-ASSOCIATION | AMERICAN-COLLEGE | RISK | ARTERY STENOSIS | ACCURACY | Predictive Value of Tests | France - epidemiology | Reproducibility of Results | Prevalence | Prospective Studies | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Coronary Artery Disease - diagnostic imaging | Coronary Angiography - methods | Female | Coronary Artery Disease - epidemiology | Odds Ratio | Studies | Cardiovascular disease | Medical imaging | Medical diagnosis | Coronary vessels | Life Sciences | Human health and pathology | Tissues and Organs
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Feasibility and Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation With the Edwards SAPIEN-XT Prosthesis
by Durand, Eric, MD, PhD and Eltchaninoff, Hélène, MD and Canville, Alexandre, MD and Bouhzam, Najime, MD and Godin, Matthieu, MD and Tron, Christophe, MD and Rodriguez, Carlos, MD and Litzler, Pierre-Yves, MD and Bauer, Fabrice, MD, PhD and Cribier, Alain, MD
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 115, Issue 8, pp. 1116 - 1122
There is currently no consensus on the duration of hospitalization required after transfemoral transcatheter aortic valve implantation (TAVI). We report the... 
Cardiovascular | REPLACEMENT | HIGH-RISK PATIENTS | COST-EFFECTIVENESS | TRIAL COHORT | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | PREDICTORS | HEART-VALVE | FOLLOW-UP | OUTCOMES | CONDUCTION DISTURBANCES | Echocardiography | Follow-Up Studies | Heart Valve Prosthesis | Humans | Male | Treatment Outcome | Aortic Valve Stenosis - diagnosis | Prosthesis Design | Feasibility Studies | Time Factors | Cardiac Catheterization - methods | Length of Stay - trends | Aged, 80 and over | Electrocardiography | Female | Femoral Artery | Aortic Valve Stenosis - surgery | Retrospective Studies | Patient Discharge - trends | Transcatheter Aortic Valve Replacement - methods | Heart valve diseases | Safety and security measures | Implants, Artificial | Prosthesis | Atrial fibrillation | Confidence intervals | Variables | Cardiac arrhythmia | Prostheses | Stroke | Intensive care | Heart attacks | Patient safety | Hospitalization | Logistics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Performance Analysis of EuroSCORE II Compared to the Original Logistic EuroSCORE and STS Scores for Predicting 30-Day Mortality After Transcatheter Aortic Valve Replacement
by Durand, Eric, MD, PhD and Borz, Bogdan, MD and Godin, Matthieu, MD and Tron, Christophe, MD and Litzler, Pierre-Yves, MD and Bessou, Jean-Paul, MD and Dacher, Jean-Nicolas, MD and Bauer, Fabrice, MD, PhD and Cribier, Alain, MD and Eltchaninoff, Hélène, MD
American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 111, Issue 6, pp. 891 - 897
The original European System for Cardiac Operative Risk Evaluation (EuroSCORE) has been recently updated as EuroSCORE II to optimize its efficacy in cardiac... 
Cardiovascular | Severity of Illness Index | Predictive Value of Tests | Risk Assessment - methods | Data Interpretation, Statistical | Prospective Studies | Heart Valve Prosthesis | Humans | Risk Factors | Heart Valve Prosthesis Implantation - mortality | Male | Treatment Outcome | Cardiac Catheterization - mortality | Cause of Death | Aortic Valve Stenosis - mortality | Algorithms | Aged, 80 and over | Female | Aged | Aortic Valve Stenosis - surgery | Heart valve diseases | Prognosis | Universities and colleges | Comparative analysis | Health aspects | Mortality | Heart failure | Confidence intervals | Cardiac arrhythmia | Heart attacks | Pulmonary arteries | Population | Sepsis | Calibration | Cardiology | Logistics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes
by Eltchaninoff, Hélène, MD and Durand, Eric, MD, PhD and Borz, Bogdan, MD and Furuta, Akira, MD and Bejar, Karim, MD and Canville, Alexandre, MD and Farhat, Ali, MD and Fraccaro, Chiara, MD and Godin, Matthieu, MD and Tron, Christophe, MD and Sakhuja, Rahul, MD and Cribier, Alain, MD
American Heart Journal, ISSN 0002-8703, 2014, Volume 167, Issue 2, pp. 235 - 240
Background The use of balloon aortic valvuloplasty (BAV) has resurged since the development of transcatheter aortic valve replacement (TAVR). The aim of our... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | IMPLANTATION | HIGH-RISK | ADULTS | TRANS-LUMINAL VALVULOPLASTY | COMPLICATIONS | Severity of Illness Index | Echocardiography | Follow-Up Studies | Humans | Heart Valve Prosthesis Implantation - methods | Male | Treatment Outcome | Aortic Valve Stenosis - diagnosis | Time Factors | Cardiac Catheterization - methods | Aged, 80 and over | Balloon Valvuloplasty - methods | Female | Aortic Valve Stenosis - surgery | Retrospective Studies | Aortic valve stenosis | Studies | Heart failure | Stroke | Heart attacks | Statistical analysis | Heart surgery | Mortality | Chronic obstructive pulmonary disease | Cardiology | Success | Logistics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A Prospective Analysis of Early Discharge after Transfemoral Transcatheter Aortic Valve Implantation
by Serletis-Bizios, Anna, MD and Durand, Eric, MD PhD and Cellier, Guillaume, MD and Tron, Christophe, MD and Bauer, Fabrice, MD PhD and Glinel, Bastien, MD and Dacher, Jean-Nicolas, MD and Cribier, Alain, MD and Eltchaninoff, Helene, MD
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 6, pp. 866 - 872
Abstract As transcatheter aortic valve implantation (TAVI) becomes more routinely employed, the recommended duration of monitoring after uncomplicated TAVI... 
Cardiovascular | REPLACEMENT | HIGH-RISK PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | FEASIBILITY | PREDICTORS | EDWARDS SAPIEN-XT | FREQUENCY | FOLLOW-UP | CONDUCTION DISTURBANCES | PROSTHESIS | Multivariate Analysis | Transcatheter Aortic Valve Replacement | Prospective Studies | Humans | Mortality | Risk Factors | Proportional Hazards Models | Male | Blood Transfusion - statistics & numerical data | Feasibility Studies | Time Factors | Pacemaker, Artificial - statistics & numerical data | Patient Discharge - statistics & numerical data | Patient Safety | Aged, 80 and over | Female | Femoral Artery | Aged | Aortic Valve Stenosis - surgery | France | Patient Readmission - statistics & numerical data | Length of Stay - statistics & numerical data | Heart valve diseases | Implants, Artificial | Prosthesis | Analysis | Cardiology | Blood transfusion | Data entry | Medical research | Medicine, Experimental | Blood transfusions | Heart failure | Heart attacks | Kidneys | Pulmonary arteries | Hospitalization | Multivariate analysis | Patients | Studies | Confidence intervals | Ultrasonic imaging | Electrocardiography | Population | Logistics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience
by Cribier, Alain and Eltchaninoff, Helene and Tron, Christophe and Bauer, Fabrice and Agatiello, Carla and Nercolini, Deborah and Tapiero, Sydney and Litzler, Pierre-Yves and Bessou, Jean-Paul and Babaliaros, Vasilis
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2006, Volume 47, Issue 6, pp. 1214 - 1223
OBJECTIVES: The aim of this work was to study the feasibility, safety, efficacy, and durability of percutaneous heart valve (PHV) implantation in the aortic... 
REPLACEMENT | MORTALITY | SURGERY | EUROSCORE | CARDIAC & CARDIOVASCULAR SYSTEMS | TRANSCATHETER IMPLANTATION | PROSTHESIS | Calcinosis - complications | Follow-Up Studies | Heart Valve Prosthesis | Humans | Middle Aged | Male | Heart Valve Diseases - surgery | Calcinosis - surgery | Feasibility Studies | Aortic Valve Stenosis - complications | Time Factors | Heart Valve Diseases - complications | Aged, 80 and over | Female | Aged | Aortic Valve Stenosis - surgery | Aortic Valve | Hypertension | Heart | Prostheses | Stroke | Heart attacks | Heart surgery | Comorbidity | Mortality | Colleges & universities | Cardiovascular disease | Patients | Pathology | Hospitals | Coronary vessels | Cardiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights